Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Translational Andrology and Urology|November 22, 2021
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysisKatrin Schlack, Laura-Maria Krabbe, Kambiz Rahbar, et al.
Journal of Biomedical Informatics|April 22, 2014
The need for harmonized structured documentation and chances of secondary use - results of a systematic analysis with automated form comparison for prostate and breast cancerRainer Krumm, Axel Semjonow, Joke Tio, et al.
Cancers|September 25, 2019
Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical ProstatectomyJulia Smentoch, Jolanta Szade, Anna J Żaczek, et al.
BMC Medical Informatics and Decision Making|December 5, 2012
CMDX©-based single source information system for simplified quality management and clinical research in prostate cancerOkyaz Eminaga, Mahmoud Abbas, Reemt Hinkelammert, et al.
Urologic Oncology|June 5, 2014
Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomyOkyaz Eminaga, Martin Bögemann, Bernhard Breil, et al.
Genes, Chromosomes & Cancer|April 3, 2008
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostateOlaf Bettendorf, Hartmut Schmidt, Annette Staebler, et al.
Urology|August 10, 2015
Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy SpecimensOkyaz Eminaga, Reemt Hinkelammert, Mahmoud Abbas, et al.
Cancers|July 9, 2022
Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based StudyOkyaz Eminaga, Eugene Shkolyar, Bernhard Breil, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 6, 2018
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancerPaulina Nastały, Martyna Filipska, Colm Morrissey, et al.
Clinical Chemistry|May 27, 2003
Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracySebastian Wesseling, Carsten Stephan, Axel Semjonow, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Translational Andrology and Urology|November 22, 2021
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysisKatrin Schlack, Laura-Maria Krabbe, Kambiz Rahbar, et al.
Journal of Biomedical Informatics|April 22, 2014
The need for harmonized structured documentation and chances of secondary use - results of a systematic analysis with automated form comparison for prostate and breast cancerRainer Krumm, Axel Semjonow, Joke Tio, et al.
Cancers|September 25, 2019
Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical ProstatectomyJulia Smentoch, Jolanta Szade, Anna J Żaczek, et al.
BMC Medical Informatics and Decision Making|December 5, 2012
CMDX©-based single source information system for simplified quality management and clinical research in prostate cancerOkyaz Eminaga, Mahmoud Abbas, Reemt Hinkelammert, et al.
Urologic Oncology|June 5, 2014
Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomyOkyaz Eminaga, Martin Bögemann, Bernhard Breil, et al.
Genes, Chromosomes & Cancer|April 3, 2008
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostateOlaf Bettendorf, Hartmut Schmidt, Annette Staebler, et al.
Urology|August 10, 2015
Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy SpecimensOkyaz Eminaga, Reemt Hinkelammert, Mahmoud Abbas, et al.
Cancers|July 9, 2022
Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based StudyOkyaz Eminaga, Eugene Shkolyar, Bernhard Breil, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|October 6, 2018
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancerPaulina Nastały, Martyna Filipska, Colm Morrissey, et al.
Clinical Chemistry|May 27, 2003
Determination of non-alpha1-antichymotrypsin-complexed prostate-specific antigen as an indirect measurement of free prostate-specific antigen: analytical performance and diagnostic accuracySebastian Wesseling, Carsten Stephan, Axel Semjonow, et al.
Pageof 11